Home › Funds › Two Seas Capital LP › INDV

Two Seas Capital LP position in INDV

INDIVIOR PHARMACEUTICALS INC · Health Care

Two Seas Capital LP reported holding 3,671,072 shares of INDV (INDIVIOR PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$131.6M, representing 1.71% of its reported portfolio and ranking #7 among its reported holdings. Two Seas Capital LP has disclosed INDV holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)3.67M sh
Reported value held$131.61M
Portfolio Weight1.71%
First reportedQ3 2023
Last changeAdd
Updated2026-10-09

Last updated: 2026-10-09 · Source: SEC EDGAR Form 13F-HR

How Two Seas Capital LP's INDV position evolved

Two Seas Capital LP first disclosed a stake in INDV in Q3 2023 at 13,670,312 shares (US$315.4M). Across 13 filings, Two Seas Capital LP increased the stake 3 time(s), trimmed it 8 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 3,671,072 shares valued at US$131.6M — an increase of 191,579 shares quarter over quarter.. Notable position changes include a 51% trim in Q4 2025 (shares fell 15% over the following quarter), a 27% trim in Q2 2026 (shares fell 13% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 13.67M $315.37M New
Q4 2023 13.81M $210.89M Add
Q1 2024 13.25M $283.84M Reduce
Q2 2024 12.63M $203.60M Reduce
Q3 2024 13.03M $127.04M Add
Q4 2024 12.46M $154.85M Reduce
Q1 2025 11.37M $106.51M Reduce
Q2 2025 11.41M $168.15M Hold
Q3 2025 10.50M $253.26M Reduce
Q4 2025 5.11M $183.32M Reduce
Q1 2026 4.75M $144.67M Reduce
Q2 2026 3.48M $142.76M Reduce
Q3 2026 3.67M $131.61M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About INDV and 13F data

INDV (INDIVIOR PHARMACEUTICALS INC) is a Health Care company. 53 other funds we track also report a position in INDV — the largest reported positions include OAKTREE CAPITAL MANAGEMENT LP (US$251.4M), Madison Avenue Partners, LP (US$117.9M), MANGROVE PARTNERS IM, LLC (US$109.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding INDV

All INDV fund holders →

FAQ

How long has Two Seas Capital LP held INDV?

Two Seas Capital LP has disclosed INDV holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Two Seas Capital LP's current position in INDV?

As of Q3 2026, Two Seas Capital LP holds 3.67M shares of INDV (INDIVIOR PHARMACEUTICALS INC), valued at $131.61M, representing 1.71% of its reported portfolio and ranking #7.

Has Two Seas Capital LP been buying or selling INDV?

In the latest 13F filing (Q3 2026), Two Seas Capital LP increased its position in INDV.

Which other funds hold INDV?

Other major institutional holders of INDV include OAKTREE CAPITAL MANAGEMENT LP, Madison Avenue Partners, LP, MANGROVE PARTNERS IM, LLC, among 53 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.